• 口腔溃疡含片与口腔溃疡散治疗Ⅲ期复发性阿弗他溃疡疗效对比
  • Comparison of the Clinical Efficacy of Oral Ulcer Buccal Tablet and Oral Ulcer Powder in the Treatment of Stage Ⅲ Recurrent Aphthous Ulcer
  • 刘博洋.口腔溃疡含片与口腔溃疡散治疗Ⅲ期复发性阿弗他溃疡疗效对比[J].中国烧伤创疡杂志,2022,(1):9~11.
    DOI:
    中文关键词:  口腔溃疡含片  口腔溃疡散  复发性阿弗他溃疡  创面  不良反应
    英文关键词:Oral ulcer buccal tablet  Oral ulcer powder  Recurrent aphthous ulcer (RAU)  Wound  Adverse reaction
    基金项目:
    作者单位
    刘博洋 110034 辽宁 沈阳沈阳七三九医院口腔科 
    摘要点击次数: 1778
    全文下载次数: 4869
    中文摘要:
          【摘要】 目的 对比分析口腔溃疡含片与口腔溃疡散治疗Ⅲ期复发性阿弗他溃疡的临床效果。方法 选取2019年6月至2020年7月沈阳七三九医院收治的200例Ⅲ期复发性阿弗他溃疡患者作为研究对象,并按照随机数表法将其随机分为含片组与散剂组,每组100例,含片组患者采用口腔溃疡含片治疗,散剂组患者采用口腔溃疡散治疗,对比两组患者临床疗效、溃疡愈合时间以及不良反应发生情况。结果 治疗7 d后,含片组患者中显效83例、有效15例、无效2例,明显优于散剂组患者的显效70例、有效17例、无效13例(Z=-2.412,P=0.016);含片组患者溃疡愈合时间为(5.25±1.39)d,明显短于散剂组患者的溃疡愈合时间(10.88±2.02)d(t=22.960,P<0.001);治疗期间,含片组患者不良反应发生率为3.00%,与散剂组患者不良反应发生率2.00%无明显差异(2=0.205,P=0.651)。结论 与口腔溃疡散相比,口腔溃疡含片可明显提高Ⅲ期复发性阿弗他溃疡患者的临床疗效,缩短溃疡愈合时间。
    英文摘要:
          【Abstract】 Objective To compare the clinical efficacy of oral ulcer buccal tablet and oral ulcer powder in the treatment of stage Ⅲ recurrent aphthous ulcer. Methods 200 patients with stage Ⅲ recurrent aphthous ulcers, admitted to Shenyang 739th Hospital from June 2019 to July 2020, were enrolled as research subjects and divided, using random number table, into buccal tablet group (n = 100) treated with oral ulcer buccal tablets, and powder group ( n = 100) treated with oral ulcer powder. The clinical efficacy, healing time of ulcer wounds and occurrence of adverse reactions were compared between the two groups. Results After 7 days of treatment, the treatment was markedly effective in 83 cases, effective in 15 cases, and ineffective in 2 cases in buccal tablet group, much better than powder group (Z =-2.412,P=0.016) in which the treatment was markedly effective in 70 cases, effective in 17 cases, and ineffective in 13 cases. The healing time of ulcer wounds in buccal tablet group was (5.25±1.39)days, much shorter than (10.88±2.02) days in powder group (t=22.960,P<0.001). During the course of treatment, the incidence of adverse reactions in buccal tablet group was 3.0%,which showed no significant difference as compared with 2.0% in powder group (2=0.205,P=0.651).Conclusion Compared with oral ulcer powder, oral ulcer buccal tablet is better in improving the therapeutic effects of patients with stage Ⅲ recurrent aphthous ulcers and shortening the healing time of ulcer wounds, presenting a much high value of clinical application.